1001-5256
2014 Issue 3
Studies on liver cancer: evolution and perspectives
TANG Zhaoyou;
TANG Zhaoyou;
..............page:193-196
..............page:196,221,232,248,256,263,275,281
Chinese standards for diagnosis and treatment of liver disease-White paper excerpt
hou jin lin ;, jia ji dong ;, niu jun qi ;, wang gui qiang ;, wei lai ;, xie qing ;, zhang wen hong ;
hou jin lin ;, jia ji dong ;, niu jun qi ;, wang gui qiang ;, wei lai ;, xie qing ;, zhang wen hong ;
..............page:197-209
Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension
Group of Gastrointestinal Intervention, Chinese So;
Group of Gastrointestinal Intervention, Chinese So;
..............page:210-213
Design and implementation of multidisciplinary holistic treatment regimen for primary liver cancer
WANG Yuehua;
WANG Yuehua;
..............page:214-217
Radiotherapy for large hepatocellular carcinoma under the guidance of surgical principle
FANG Ziyan;,LI Gong;
FANG Ziyan;,LI Gong;
..............page:218-221
Brivanib for treatment of hepatocellular carcinoma: an overview of clinical trials
bai wei ;, fan dai ming ;, han guo hong ;, qi xing shun ;, ren wei zuo ;, yang man ;
bai wei ;, fan dai ming ;, han guo hong ;, qi xing shun ;, ren wei zuo ;, yang man ;
..............page:222-224
Regorafenib for treatment of hepatocellular carcinoma: an overview of clinical trials
bai ming ;, chen hui ;, fan dai ming ;, han guo hong ;, jia jia ;, liu lei ;, qi xing shun ;
bai ming ;, chen hui ;, fan dai ming ;, han guo hong ;, jia jia ;, liu lei ;, qi xing shun ;
..............page:225-227
Research progress in serum microRNA detection for diagnosis of hepatocellular carcinoma
LU Jun;,QU Yachao;
LU Jun;,QU Yachao;
..............page:228-232
Advances in treatment of advanced hepatocellular cancer
CHENG Peng;,LI Yan;
CHENG Peng;,LI Yan;
..............page:233-236
Precise radiotherapy and chemoradiotherapy for localized pancreatic cancer
WANG Jing;,XIA Tingyi;
WANG Jing;,XIA Tingyi;
..............page:237-241
Application of contrast-enhanced ultrasound in hepatectomy for primary liver cancer: a report of 42 cases
GE Minggang;,ZHANG Wei;,ZHU Yu;
GE Minggang;,ZHANG Wei;,ZHU Yu;
..............page:242-244
Dosimetric comparison of 3DCRT and IMRT in treatment of primary hepatocellular carcinoma with portal vein tumor thrombus
li zuo ;, li zhong hua ;, luo zhan xiong ;, shi cheng liang ;, yu bin ;, zhang si xing ;, zheng qing ping ;, zhou zuo zuo ;
li zuo ;, li zhong hua ;, luo zhan xiong ;, shi cheng liang ;, yu bin ;, zhang si xing ;, zheng qing ping ;, zhou zuo zuo ;
..............page:245-248
Expression and clinical significance of Gremlin-1 in patients with primary liver cancer and liver cirrhosis
chen lin ;, guo yong hong ;, he zuo ;, ji guang xi ;, jia xiao li ;, jia zhan sheng ;, di song ;, zhang ying ;, zhou yun ;
chen lin ;, guo yong hong ;, he zuo ;, ji guang xi ;, jia xiao li ;, jia zhan sheng ;, di song ;, zhang ying ;, zhou yun ;
..............page:249-252
Expression of Caspase-9 and Survivin in hepatocellular carcinoma tissues and its clinical significance
guo xiao dong ;, li zhi wei ;, xiong zuo ;, yang mei ;
guo xiao dong ;, li zhi wei ;, xiong zuo ;, yang mei ;
..............page:253-256
Efficacy of argon-helium cryoablation combined with I125 particle implantation in treatment of hilar cholangiocarcinoma: a report of 5 cases
ye jin hua ;, ye qi wen ;, zhan wen feng ;, zhang chun ;
ye jin hua ;, ye qi wen ;, zhan wen feng ;, zhang chun ;
..............page:257-259
Expression and clinical significance of DLK1 and MMP-9 in cholangiocarcinoma
chen yan ling ;, li xiu jin ;, tang nan hong ;, wang xiao zuo ;
chen yan ling ;, li xiu jin ;, tang nan hong ;, wang xiao zuo ;
..............page:260-263
Anti-gallbladder carcinoma activity of a novel nano-drug delivery system based on 3D cell culture model
bian zuo ;, jiang han ;, li yong sheng ;, shi wei bin ;, wang zi hao ;
bian zuo ;, jiang han ;, li yong sheng ;, shi wei bin ;, wang zi hao ;
..............page:264-268
Drug resistance mutations related to nucleos(t)ide analogues in Chinese patients with chronic HBV infection: an analysis of 153 cases
lin fei ;, zuo zuo ;, xu xiao yuan ;, yao bei ;
lin fei ;, zuo zuo ;, xu xiao yuan ;, yao bei ;
..............page:269-273
Misdiagnosis of intrahepatic biliary cystadenoma with cystadenocarcinoma: a report of one case
QIU Wei;,WANG Chunxu;,WANG Guangyi;
QIU Wei;,WANG Chunxu;,WANG Guangyi;
..............page:274-275
Primary undifferentiated polymorphic sarcoma in gallbladder: a report of one case
LI Ming;,LIU Yan;,WANG Yong;
LI Ming;,LIU Yan;,WANG Yong;
..............page:276-277
Sorafenib-related adverse events in treatment of hepatocellular carcinoma
HAN Guohong;,QI Xingshun;,YANG Man;
HAN Guohong;,QI Xingshun;,YANG Man;
..............page:278-281
Role of Golgi secretory clusterin expression in progression of hepatocellular carcinoma
YAO Dengfu;,ZHENG Wenjie;
YAO Dengfu;,ZHENG Wenjie;
..............page:282-284
The role of hepatic stellate cells in development and progression of hepatocellular carcinoma
CHEN Qiming;,CHEN Qingfeng;
CHEN Qiming;,CHEN Qingfeng;
..............page:285-288